Y-mAbs Therapeutics Inc. (YMAB) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Y-mAbs Therapeutics Inc.

    NASDAQ: YMAB · Real-Time Price · USD
    8.58
    0.01 (0.12%)
    At close: Sep 05, 2025, 3:59 PM
    8.58
    0.00%
    After-hours: Sep 05, 2025, 04:24 PM EDT

    Y-mAbs Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -11.7 -13.89 -2.23 -12.66
    PEG Ratio
    		 -0.32 0.18 -0.03 0.22
    PS Ratio
    		 3.96 3.51 3.27 20.06
    PB Ratio
    		 3.77 2.95 1.95 3.89
    P/FCF Ratio
    		 -22.09 -10.93 -2.81 -6.76
    P/OCF Ratio
    		 -22.09 -10.93 -2.81 -6.83
    OCF/S Ratio
    		 -0.18 -0.32 -1.16 -2.94
    Debt / Equity Ratio
    		 0.01 0.01 0.02 0.02
    Quick Ratio
    		 3.85 5.27 4.38 7.06
    Current Ratio
    		 4.16 5.52 4.61 7.26
    Asset Turnover
    		 0.73 0.66 0.46 0.16
    Interest Coverage
    		 n/a n/a -125.25 -62.33
    Return on Equity
    		 -0.32 -0.21 -0.87 -0.31
    Return on Assets
    		 -0.25 -0.17 -0.68 -0.26
    Return on Invested Capital
    		 -0.32 -0.24 -0.83 -0.62
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.83 0.87 0.88 0.93
    Net Profit Margin
    		 -0.34 -0.25 -1.46 -1.58
    Pretax Profit Margin
    		 -0.34 -0.25 -1.46 -1.58
    Operating Profit Margin
    		 -0.36 -0.3 -1.45 -3.31
    FCF Margin
    		 -0.18 -0.32 -1.16 -2.97
    EBITDA Margin
    		 -0.35 -0.29 -1.45 -1.56

    Add to Watchlist